Cargando…
Factors Influencing the Surgical Decision in Dystonia Patients Referred for Deep Brain Stimulation
There is no available data on the journey of dystonia patients once referred to a tertiary center to undergo deep brain stimulation (DBS). We hypothesized that some patients might be incorrectly diagnosed while others might decline the procedure or experience significant benefit with switching to a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402533/ https://www.ncbi.nlm.nih.gov/pubmed/34437382 http://dx.doi.org/10.3390/toxins13080511 |
_version_ | 1783745812625358848 |
---|---|
author | Gorodetsky, Carolina Azevedo, Paula Candeias da Silva, Carolina Fasano, Alfonso |
author_facet | Gorodetsky, Carolina Azevedo, Paula Candeias da Silva, Carolina Fasano, Alfonso |
author_sort | Gorodetsky, Carolina |
collection | PubMed |
description | There is no available data on the journey of dystonia patients once referred to a tertiary center to undergo deep brain stimulation (DBS). We hypothesized that some patients might be incorrectly diagnosed while others might decline the procedure or experience significant benefit with switching to a different botulinum neurotoxin (BoNT). This is a single-center, retrospective study of dystonia patients who were referred to the DBS program between January 2014 and December 2018. We collected data on the surgical decision as well as factors influencing this decision. Sixty-seven patients were included (30 males, mean age: 48.3 ± 20.1 years, disease duration: 16.9 ± 15.3 years). Thirty-three (49%) patients underwent DBS. Four (6%) patients were awaiting the procedure while the remaining 30 patients (45%) did not undergo DBS. Reasons for DBS decline were patient refusal (17, 53%), functional dystonia (6, 20%), and successful use of AbobotulinumtoxinA (3, 10%) in patients who had failed other BoNTs. Our study highlights the importance of structured patient education to increase acceptance of DBS, as well as careful patient evaluation, particularly with respect to functional dystonia. Finally, changing BoNT formulation might be beneficial in some patients. |
format | Online Article Text |
id | pubmed-8402533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84025332021-08-29 Factors Influencing the Surgical Decision in Dystonia Patients Referred for Deep Brain Stimulation Gorodetsky, Carolina Azevedo, Paula Candeias da Silva, Carolina Fasano, Alfonso Toxins (Basel) Article There is no available data on the journey of dystonia patients once referred to a tertiary center to undergo deep brain stimulation (DBS). We hypothesized that some patients might be incorrectly diagnosed while others might decline the procedure or experience significant benefit with switching to a different botulinum neurotoxin (BoNT). This is a single-center, retrospective study of dystonia patients who were referred to the DBS program between January 2014 and December 2018. We collected data on the surgical decision as well as factors influencing this decision. Sixty-seven patients were included (30 males, mean age: 48.3 ± 20.1 years, disease duration: 16.9 ± 15.3 years). Thirty-three (49%) patients underwent DBS. Four (6%) patients were awaiting the procedure while the remaining 30 patients (45%) did not undergo DBS. Reasons for DBS decline were patient refusal (17, 53%), functional dystonia (6, 20%), and successful use of AbobotulinumtoxinA (3, 10%) in patients who had failed other BoNTs. Our study highlights the importance of structured patient education to increase acceptance of DBS, as well as careful patient evaluation, particularly with respect to functional dystonia. Finally, changing BoNT formulation might be beneficial in some patients. MDPI 2021-07-22 /pmc/articles/PMC8402533/ /pubmed/34437382 http://dx.doi.org/10.3390/toxins13080511 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gorodetsky, Carolina Azevedo, Paula Candeias da Silva, Carolina Fasano, Alfonso Factors Influencing the Surgical Decision in Dystonia Patients Referred for Deep Brain Stimulation |
title | Factors Influencing the Surgical Decision in Dystonia Patients Referred for Deep Brain Stimulation |
title_full | Factors Influencing the Surgical Decision in Dystonia Patients Referred for Deep Brain Stimulation |
title_fullStr | Factors Influencing the Surgical Decision in Dystonia Patients Referred for Deep Brain Stimulation |
title_full_unstemmed | Factors Influencing the Surgical Decision in Dystonia Patients Referred for Deep Brain Stimulation |
title_short | Factors Influencing the Surgical Decision in Dystonia Patients Referred for Deep Brain Stimulation |
title_sort | factors influencing the surgical decision in dystonia patients referred for deep brain stimulation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402533/ https://www.ncbi.nlm.nih.gov/pubmed/34437382 http://dx.doi.org/10.3390/toxins13080511 |
work_keys_str_mv | AT gorodetskycarolina factorsinfluencingthesurgicaldecisionindystoniapatientsreferredfordeepbrainstimulation AT azevedopaula factorsinfluencingthesurgicaldecisionindystoniapatientsreferredfordeepbrainstimulation AT candeiasdasilvacarolina factorsinfluencingthesurgicaldecisionindystoniapatientsreferredfordeepbrainstimulation AT fasanoalfonso factorsinfluencingthesurgicaldecisionindystoniapatientsreferredfordeepbrainstimulation |